Imagine an implant that requires no batteries, wires, or complex surgery. Just apply a magnetic field — and neurons become activated. Sounds like science fiction? Not anymore!
We present a new study in which the already well-known biocompatible magnetoelectric nanoparticles MFO@BCZT demonstrated outstanding performance in wireless brain stimulation. This is not just another synthesis study — it is a real story about how processing parameters can change everything.
What was done?
🧪 Nanoparticles as small as 22 nm were developed, featuring an ultrathin ferroelectric BCZT shell (2–6 nm).
⚙️ The synthesis employed a “smart” microwave-assisted hydrothermal method. By tuning the temperature (185 → 225 °C), NaOH concentration, and synthesis duration, we learned how to precisely control the nanoparticle structure and properties.
The main breakthrough:
It turned out that lowering the synthesis temperature to 185 °C was the magic key:
🔹 The intermediate Ba₁.₁₂Ti₈O₁₆₋δ phase disappeared (it appeared only at higher temperatures).
🔹 The piezoelectric response increased up to 18.25 ± 7.32 pm/V.
🔹 The magnetoelectric response became more than 3 times higher (up to 1.8×10⁶ mV·cm⁻¹·Oe⁻¹), one of the best values reported among all magnetoelectric nanoparticles!
What does this mean for real biology?
Neurons interacting with nanoparticles synthesized at 185 °C showed:
✔️ 20% more active cells.
✔️ A more than threefold increase in calcium response (Ca²⁺ signaling) under a low-intensity alternating magnetic field (up to 6 mT, 50 Hz) compared with the control group.
Why is this important?
This work demonstrates that even without changing the chemical composition, targeted optimization of synthesis parameters can dramatically improve material performance. MFO@BCZT is no longer just a laboratory sample, but a prototype platform for neural interfaces. We now understand how to enhance efficiency: through control of phase composition and shell defect engineering.
The next steps are scaling up production and conducting long-term in vivo biocompatibility studies — and the path toward clinical implants for treating Parkinson’s disease, epilepsy, or post-traumatic recovery may become reality.
Read the full article here:
https://www.sciencedirect.com/science/article/pii/S0272884226013271?dgcid=coauthor#Neurostimulation #Nanoparticles #Magnetoelectrics #WirelessImplants #Biocompatibility #NeuralInterfaces #MaterialsScience #Breakthrough #MNICPMEM #Research #TPU